Brief: Dicot Pharma Announces Prelim Rights Issue Outcome
05/06/2026 07:37
BRIEF-Dicot Pharma Announces Prelim Rights Issue Outcome June 5 (Reuters) - Dicot Pharma AB DICOT.ST:
SAID ON THURSDAY PRELIMINARY OUTCOME OF RIGHTS ISSUE
PRELIM OUTCOME INDICATES 194,364,088 UNITS HAVE BEEN SUBSCRIBED FOR, CORRESPONDING TO ABOUT 126% OF RIGHTS ISSUE
INDICATES THAT UNDERWRITING COMMITMENTS WILL NOT BE CALLED UPON
WILL PRELIMINARILY RECEIVE ABOUT SEK 210 MILLION BEFORE DEDUCTION OF COSTS
TO INCREASE OFFERING THROUGH DIRECTED SHARE ISSUE OF UP TO ADDITIONAL ABOUT SEK 21 MILLION
Source text for Workspace: nMFN8vgm4t
Further company coverage: DICOT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue
Brief: Dicot Pharma Announces Prelim Rights Issue Outcome
Brief: Dicot Pharma Submits IND Application To FDA